Cargando…
Tackling malignant melanoma epigenetically: histone lysine methylation
Post-translational histone modifications such as acetylation and methylation can affect gene expression. Histone acetylation is commonly associated with activation of gene expression whereas histone methylation is linked to either activation or repression of gene expression. Depending on the site of...
Autores principales: | , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6249913/ https://www.ncbi.nlm.nih.gov/pubmed/30466474 http://dx.doi.org/10.1186/s13148-018-0583-z |
_version_ | 1783372848467804160 |
---|---|
author | Orouji, Elias Utikal, Jochen |
author_facet | Orouji, Elias Utikal, Jochen |
author_sort | Orouji, Elias |
collection | PubMed |
description | Post-translational histone modifications such as acetylation and methylation can affect gene expression. Histone acetylation is commonly associated with activation of gene expression whereas histone methylation is linked to either activation or repression of gene expression. Depending on the site of histone modification, several histone marks can be present throughout the genome. A combination of these histone marks can shape global chromatin architecture, and changes in patterns of marks can affect the transcriptomic landscape. Alterations in several histone marks are associated with different types of cancers, and these alterations are distinct from marks found in original normal tissues. Therefore, it is hypothesized that patterns of histone marks can change during the process of tumorigenesis. This review focuses on histone methylation changes (both removal and addition of methyl groups) in malignant melanoma, a deadly skin cancer, and the implications of specific inhibitors of these modifications as a combinatorial therapeutic approach. |
format | Online Article Text |
id | pubmed-6249913 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2018 |
publisher | BioMed Central |
record_format | MEDLINE/PubMed |
spelling | pubmed-62499132018-11-26 Tackling malignant melanoma epigenetically: histone lysine methylation Orouji, Elias Utikal, Jochen Clin Epigenetics Review Post-translational histone modifications such as acetylation and methylation can affect gene expression. Histone acetylation is commonly associated with activation of gene expression whereas histone methylation is linked to either activation or repression of gene expression. Depending on the site of histone modification, several histone marks can be present throughout the genome. A combination of these histone marks can shape global chromatin architecture, and changes in patterns of marks can affect the transcriptomic landscape. Alterations in several histone marks are associated with different types of cancers, and these alterations are distinct from marks found in original normal tissues. Therefore, it is hypothesized that patterns of histone marks can change during the process of tumorigenesis. This review focuses on histone methylation changes (both removal and addition of methyl groups) in malignant melanoma, a deadly skin cancer, and the implications of specific inhibitors of these modifications as a combinatorial therapeutic approach. BioMed Central 2018-11-22 /pmc/articles/PMC6249913/ /pubmed/30466474 http://dx.doi.org/10.1186/s13148-018-0583-z Text en © The Author(s). 2018 Open AccessThis article is distributed under the terms of the Creative Commons Attribution 4.0 International License (http://creativecommons.org/licenses/by/4.0/), which permits unrestricted use, distribution, and reproduction in any medium, provided you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated. |
spellingShingle | Review Orouji, Elias Utikal, Jochen Tackling malignant melanoma epigenetically: histone lysine methylation |
title | Tackling malignant melanoma epigenetically: histone lysine methylation |
title_full | Tackling malignant melanoma epigenetically: histone lysine methylation |
title_fullStr | Tackling malignant melanoma epigenetically: histone lysine methylation |
title_full_unstemmed | Tackling malignant melanoma epigenetically: histone lysine methylation |
title_short | Tackling malignant melanoma epigenetically: histone lysine methylation |
title_sort | tackling malignant melanoma epigenetically: histone lysine methylation |
topic | Review |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6249913/ https://www.ncbi.nlm.nih.gov/pubmed/30466474 http://dx.doi.org/10.1186/s13148-018-0583-z |
work_keys_str_mv | AT oroujielias tacklingmalignantmelanomaepigeneticallyhistonelysinemethylation AT utikaljochen tacklingmalignantmelanomaepigeneticallyhistonelysinemethylation |